A recent report published by Infinium Global Research on
autoimmune disease drug market provides an in-depth analysis of segments and
sub-segments in the global as well as regional autoimmune disease drug market.
The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional autoimmune disease drug market over the
short term as well as long term. The report is a comprehensive presentation of
trends, forecast and dollar values of the global autoimmune disease drug market.
According to the report, the global autoimmune disease drug market is projected
to grow at a CAGR of 4.3% over the forecast period of 2019-2025.
Autoimmune diseases are diseases caused due to dysfunction of the
immune system. The immune system is the body's defense against infections and
diseases. However, sometimes the natural system of the body fails to recognize
between own cells and foreign cells, leading to produce autoantibodies that
kill normal cells and healthy tissues and can affect any body part. By far more
than 80 autoimmune diseases are been identified which includes rheumatoid
arthritis, lupus, multiple sclerosis, psoriasis, etc. Out of these autoimmune
diseases, some are life-threatening while some of them need treatment for a
lifetime and some may also lead to disability. In female children and women,
autoimmune disease is one of the leading causes of death.
An increasing population of autoimmune disease is one of the key
factors driving the autoimmune disease drug market. As per the statistics of
the National Institute of Health, approximately 23.5 million Americans have
autoimmune diseases, among this 75 % are women. Moreover, initiatives taken by
the government and private sector for spreading awareness regarding autoimmune
disease is likely to boost the drug market. However, late or troublesome
diagnosis owing to a lack of understanding of autoimmune diseases, their causes
and their symptoms may hamper the growth of the market. Additionally, the
long-term side effects of the drugs may also hold back the growth of the
market. Furthermore, due to a substantial rise in biopharmaceutical research
companies to generate innovative approaches and drugs for disease treatment as
well as raising funds for the advancement of technologies will have greater
opportunities for the autoimmune disease drug market during the forecast
Geographically, the market can be segmented into North America,
Europe, Asia Pacific, and RoW. North America dominates the market due to its
huge population affected by autoimmune disease and increasing research
activities to speed up the development of new treatment options. Europe's
market is expected to grow due to its escalation in awareness among people
about autoimmune diseases and the involvement of government and private sectors
to upgrade methods of diagnosis as well as prevention and management of the disease.
On the other hand, the market in the Asia Pacific region is expected to grow
during the forecast period owing to the considerable rise in healthcare
The report on the global autoimmune disease drug market covers
segments such as indication, drug class, and distribution channel. On the basis
of indication, the sub-markets include diabetes mellitus type 1, rheumatic
diseases, multiple sclerosis, rare diseases, and other indication. On the basis
of drug class, the sub-markets include NSAIDs, anti-inflammatory, interferons,
antihyperglycemic, immunosuppressants, and other drug class. On the basis of
distribution channel, the sub-markets include hospital pharmacies, online
stores, and retail pharmacies.
The report provides profiles of the companies in the market such
as F. Hoffmann-La Roche AG, Abbott Laboratories, Bristol-Myers Squibb Company,
Amgen Inc., Johnson & Johnson, AstraZeneca plc, Pfizer Inc., Novartis AG,
and other companies.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of the autoimmune
disease drug market. Moreover, the study highlights current market trends and
provides forecast from 2019-2025. We also have highlighted future trends in the
market that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.